Perfil
Albertien Greijdanus was the founder of Alleviant Medical, Inc. and held the title of Director & Chief Compliance Officer since its founding in 2017.
Ms. Greijdanus is currently a Senior Investment Manager at Brabantse Ontwikkelings Maatschappij Holding BV, starting in 2024.
Education includes an undergraduate degree from Delft University of Technology conferred in 2008 and a graduate degree conferred in 2011.
Cargos activos de Albertien Greijdanus
| Empresas | Cargo | Inicio |
|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest. | Inversor de Capital Privado | 01/01/2024 |
Antiguos cargos conocidos de Albertien Greijdanus.
| Empresas | Cargo | Fin |
|---|---|---|
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Fundador | - |
Formación de Albertien Greijdanus.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe primarily in Netherlands. The firm focuses on decentralized energy systems, medtech & life sciences, plant based, deep tech, AI-tech and defense sectors. It participates in early stage capital requirements with an investment size between EUR 0.2 and 5 million. The firm acquires minority interest. | Finance |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Commercial Services |
- Bolsa de valores
- Insiders
- Albertien Greijdanus
















